145 related articles for article (PubMed ID: 38202076)
1. The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification.
Hu X; Wang X; Yu X; Ni L; Gao C; Pan X; Ren H; Xu J; Ma J
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202076
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Characteristics and Outcomes of PLA
Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
[TBL] [Abstract][Full Text] [Related]
3. The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy.
Chen Y; Xu Y; Chen S; Yu Y; Zhu X; Chen J
Ren Fail; 2023; 45(2):2264939. PubMed ID: 37814415
[TBL] [Abstract][Full Text] [Related]
4. The association of serum anti-PLA2R antibody and glomerular PLA2R antigen staining with clinical manifestations and outcomes in membranous nephropathy.
Yang SF; Xie XF; Lu WH; Lan P; Liu H; Jin L
Clin Exp Nephrol; 2023 Dec; 27(12):1060-1066. PubMed ID: 37668806
[TBL] [Abstract][Full Text] [Related]
5. Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining.
Luo J; Zhang W; Su C; Zhou Z; Wang G
Nephrol Dial Transplant; 2021 Dec; 36(12):2216-2223. PubMed ID: 33236093
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies.
Li X; Shen Y; Li Y; Ma L; Sun Q
Ren Fail; 2024 Dec; 46(1):2297015. PubMed ID: 38275176
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the status of phospholipase A2 receptor and prognosis of idiopathic membranous nephropathy.
Li YQ; Liu ZZ; Lin KX; Liu RH; Ni L; Liu GX; Lan HY; Shi YJ
Nephrology (Carlton); 2020 Feb; 25(2):144-149. PubMed ID: 31226230
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.
Hayashi N; Akiyama S; Okuyama H; Matsui Y; Adachi H; Yamaya H; Maruyama S; Imai E; Matsuo S; Yokoyama H
Clin Exp Nephrol; 2015 Oct; 19(5):797-803. PubMed ID: 25492250
[TBL] [Abstract][Full Text] [Related]
10. [C1q or IgA deposition in glomeruli of children with primary membranous nephropathy].
Xu K; Wang F; Wang ZH; Sun LY; Yao Y; Xiao HJ; Liu XY; Su BG; Zhong XH; Guan N; Zhang HW; Ding J
Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):901-907. PubMed ID: 36038299
[No Abstract] [Full Text] [Related]
11. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
[TBL] [Abstract][Full Text] [Related]
12. Utility of serum anti-phospholipase A2 receptor antibody as a biomarker in membranous nephropathy: An experience from a tertiary care center of Eastern India.
Mukherjee S; Kumar A; Maity P; Sengupta M; Basu K; Chaudhury AR; Bandopadhyay M; Chakraborty BC
Indian J Pathol Microbiol; 2023; 66(2):269-277. PubMed ID: 37077067
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
Pourcine F; Dahan K; Mihout F; Cachanado M; Brocheriou I; Debiec H; Ronco P
PLoS One; 2017; 12(3):e0173201. PubMed ID: 28257452
[TBL] [Abstract][Full Text] [Related]
14. Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy.
Song EJ; Jeong KH; Yang YA; Lim JH; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Kidney Res Clin Pract; 2018 Sep; 37(3):248-256. PubMed ID: 30254849
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
16. Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy.
Jurubiță R; Obrișcă B; Sorohan B; Achim C; Micu GE; Mircescu G; Ismail G
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34203607
[TBL] [Abstract][Full Text] [Related]
17. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.
Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB
BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003
[TBL] [Abstract][Full Text] [Related]
18. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.
Hoxha E; Thiele I; Zahner G; Panzer U; Harendza S; Stahl RA
J Am Soc Nephrol; 2014 Jun; 25(6):1357-66. PubMed ID: 24610926
[TBL] [Abstract][Full Text] [Related]
20. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
